Drug intelligence / Profile preview

ethylmorphine

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intravenous, Subcutaneous, Intramuscular, Rectal
01

Overview

Ethylmorphine is a semi-synthetic opioid analgesic and antitussive agent derived from morphine. It is used primarily to treat coughs associated with colds and lung infections, as well as for its pain-relieving properties. Ethylmorphine acts mainly as an agonist at the mu-opioid receptor (OPRM1), producing analgesia and suppression of the cough reflex. It is metabolized in the liver by cytochrome P450 enzymes—primarily CYP2D6 (O-deethylation to morphine) and CYP3A4 (N-demethylation)—and its effects are mediated through both direct action on opioid receptors and conversion to active metabolites such as morphine[2][4][6]. Ethylmorphine is not marketed in the United States but remains approved in several other countries; it is classified as a Schedule II controlled substance when used alone due to its high potential for abuse[1][2].

Brand names
Dionin
Other names
ethyl morphineethylmorphine hydrochloride
02

Targets

MOR (Mu opioid receptor)

Beyond the preview

Go deeper on ethylmorphine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ethylmorphine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call